coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Horsham Collaborative PCN, Horsham · Health Inequalities Profile

    PCN U96386 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    35,327

    Registered population

    58.0% aged 18–64

    19.6%

    Aged 65+

    ICB 21.9% · England 17.9%

    7.7%

    Ethnic minority (non-White)

    3.4% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    5,113

    Hypertension register

    +5.82% in 3 yrs · England +5.60%

    272

    SMI register

    21.4% of Horsham's

    441

    COPD register

    Reviews -2.91% in 3 yrs

    Forecast to 2030

    6,211

    Hypertension patients, 2030

    +1,098 on today

    72.1%

    QRISK ≥20% on statins, 2030

    +4.43pp over 3 yrs

    4.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -8.0%
    Dementia prevalence fell while comparators rose.

    Recorded dementia prevalence is 0.5% (Horsham 0.9%, England 0.8%) and changed -8.0% over 2023 to 2025 (England +6.0%), which may reflect unverified coding gaps.

    41.5 pp
    Wide practice variation in telephony and immunisation.

    Easy phone contact spans 41.5 pp (The Courtyard Surgery 40.1%, Cowfold Surgery 81.6%) and QOF vaccination achievement spans 47.2 pp, testable by practice audits.

    75.6%
    Blood pressure and SMI checks exceed England.

    Blood pressure control under 80 reaches 75.6% (Horsham 71.5%, England 67.8%), and SMI blood pressure checks reach 85.9% (England 83.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Children comprise 22.4% of registered patients alongside 951 catchment care home beds

    Among 35,327 registered patients, children aged 0-17 comprise 22.4% (7,910), higher than Horsham (18.7%), NHS Sussex Integrated Care Board (17.7%) and England (19.6%). Conversely, patients aged 65+ account for 19.6% (6,919), below Horsham (23.7%) and the ICB (21.9%), but above England (17.9%). Local Census usual residents are 92.3% White (Horsham 93.6%, ICB 91.0%, England 81.1%), indicating a 7.7% ethnic minority share. Primary care list size is projected to expand 5.3% by 2030 (Horsham 4.4%, ICB 2.1%, England 2.3%) under unverified methodology. Note that Census ethnicity describes area residents rather than practice-confirmed registrations.

    Age profile

    0–1722.4%
    18–6458.0%
    65+19.6%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White92.3%
    Asian3.4%
    Mixed2.4%
    Black1.1%
    Other0.7%

    Older people · falls rows are Horsham local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Horsham LA)2,1542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)88.4%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Horsham LA)9099819552024/25
    Falls deaths, all ages, per 100,000 (Horsham LA)10.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 8.2 with 0.0% Core20 registered patients across all practices

    The PCN has an average IMD decile of 8.2, in line with Horsham (8.2 decile) and above NHS Sussex Integrated Care Board (6.1 decile) and England (5.5 decile). The Core20 cohort is 0.0% (0 patients), matching Horsham (0.0%) but below NHS Sussex Integrated Care Board (9.2%) and England (21.0%). Across 61 associated areas, Cowfold Surgery, Rudgwick Medical Centre, The Courtyard Surgery, and Village Surgery each record 0.0% Core20 patients. With zero Core20 areas, local health inequality work focuses on clinical inclusion cohorts rather than area-based deprivation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Cowfold0.0% · 0 patients
    Rudgwick0.0% · 0 patients
    Courtyard0.0% · 0 patients
    Village0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    272

    SMI register

    0.75% recorded prevalence

    142

    Learning disability register

    0.39% recorded prevalence

    23

    Care homes, 951 beds

    In the PCN catchment

    8.0%

    Provide unpaid care

    Horsham, Census 2021

    Recorded learning disability prevalence is 0.4% (142 patients) and severe mental illness is 0.8% (272), both below England (0.6% and 1.0%). Catchment care homes provide 951 beds across 23 sites. District snapshot data records 9 rough sleepers, alongside an estimated ceiling of about 2,800 unpaid carers. Lower recorded prevalence across inclusion registers does not establish unmet need, but local register searches could verify diagnostic identification.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reached 85.9% (England 83.4%) and BMI checks reached 89.3% (England 82.1%). However, smoking cessation offers fell 2.3 pp (England +0.1 pp) to 91.7% (England 94.2%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,113

    Hypertension register

    +5.82%

    Register growth, 3 yrs

    Horsham +4.65% · England +5.60%

    +5.01pp

    BP control, under 80

    ≤140/90 · +3.95pp aged 80+

    +1,098

    More patients by 2030

    Forecast 6,211 (15.84%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 14.2% (5,113 patients), below Horsham (16.8%), NHS Sussex ICB (16.3%) and England (15.2%), varying locally from 12.3% at The Courtyard Surgery to 16.8% at Cowfold Surgery. This lower crude rate is consistent with a younger list (19.6% aged 65+ vs Horsham 23.7%), though observation periods were not supplied. Clinical processes are strong: 94.5% had a recent blood pressure check (England 90.0%), and 77.4% were treated to target (England 70.3%), with blood pressure control under 80 reaching 75.6% (England 67.8%). Lower crude prevalence alongside high treatment control could reflect demographic composition or case-finding variation across practices.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 62.2%, below England (63.6%) but above NHS Sussex ICB (60.0%). Lipid-regulating prescribing was 1,694 items per 1,000 adults, below England (4,100). Lower prescribing rates than England may warrant clinical review of primary prevention initiation.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202646,431£2.50£2.42£1.86£116,078
    Cardiovascular (all), 202557,819£4.42£3.32£3.33£255,560

    In 2026, lipid-modifying drugs cost £2.50 per item across 46,431 items, compared with £1.86 in England, £2.42 in NHS Sussex ICB and £2.64 in Horsham. This unit cost represents £29,716 more than at England's unit cost. This unit-cost indicator does not establish inefficient prescribing, but could prompt review of lipid-modifying formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +12.27%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.39%

    Asthma prevalence, PCN 3-yr % change

    Asthma review coverage rose 12.3% over 2023 to 2025 (England +4.4%) to 65.3% (England 65.7%), leaving about 760 unreviewed patients across a register of 2,205. For patients aged 5-19, asthma management prescribing was 774 items per 1,000 (England 1,488). COPD recorded prevalence is 1.2% (441 patients; England 1.9%), implying an unadjusted gap of +83 to +228 patients. Although COPD reviews reached 79.6% (England 76.4%), coverage fell 2.9% over 2023 to 2025 (England +2.8%).

    Cancer register and children's immunisation

    Cancer register prevalence is 3.9% (1,396 patients), in line with England (3.8%). In Q1 2025/26, MMR1 coverage at age 5 reached 96.0%, exceeding the 95.0% target. However, MMR2 was 10.9 pp lower at 85.1% (9.9 pp below target), and the 4-in-1 pre-school booster reached 83.2% (11.8 pp below target). This drop-off could reflect call-recall attrition that local practice reviews could verify.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.7%

    England 91.0%

    6-in-1 complete primary course at 24 months96.5%

    England 92.2%

    MMR dose 1 at 24 months91.8%

    England 88.3%

    MMR dose 2 at age 585.1%

    England 82.8%

    4-in-1 pre-school booster at age 583.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    Across NHS Sussex ICB in 2022, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028. ICB staging completeness was 64.3% (8,209 of 12,766 registered cancers). Sizing this gap indicates about 1,360 additional early-stage cases annually would be needed across the ICB. These ICB figures reflect wider system staging rather than PCN performance. At PCN level, breast screening coverage was 71.6% (Horsham 73.4%, England 69.9%), with 3-year change of -0.04% over 2023 to 2024 (England +8.4%), while practice coverage was 67.8% at The Courtyard Surgery.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data, provider Surrey and Sussex Healthcare NHS Trust achieved 70.0% on the cancer 62-day standard, below the 85.0% standard, NHS Surrey and Sussex ICB (71.5%) and England (71.2%), while Royal Surrey NHS Foundation Trust reached 84.5% and University Hospitals Sussex NHS Foundation Trust achieved 65.2%. Faster diagnosis (28-day) reached 77.7% (standard 75.0%). Trust 6-week diagnostic waits were 28.5% across all tests (England 23.1%), with non-obstetric ultrasound at 32.3% and echocardiography at 43.8%. These figures describe wider acute system performance rather than PCN delivery.

    Pathways within standard (%)Surrey and Sussex HealthcareSussexRoyal SurreySurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)77.7474.0182.6279.2979.32
    31-day treatment (96%)96.2076.7996.4390.4592.50
    62-day referral to treatment (85%)69.9765.2084.4871.5171.16
    Diagnostic waits over 6 weeks (%)Surrey and Sussex HealthcareSussexRoyal SurreyEngland
    MRI27.535.620.0021.40
    CT18.498.570.159.92
    Echocardiography43.780.391.5528.48
    Colonoscopy15.1139.350.0030.83
    Gastroscopy21.0620.020.0029.02
    All 15 DM01 tests28.5012.958.8223.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). Provisional community services data for June 2026 shows 72.7% of contacts among Horsham borough residents were for adults aged 65 and over (56,740 of 78,050 contacts). This local authority measure describes wider community service use rather than PCN-level activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access varies by 41.5 pp and vaccination achievement spans 47.2 pp

    In 2025/26, overall QOF achievement ranged from 88.9% at The Courtyard Surgery to 97.7% at Rudgwick Medical Centre. Vaccination and immunisation achievement showed a 47.2 pp span, from 32.4% at The Courtyard Surgery to 79.5% at Rudgwick Medical Centre (England 55.2%). High overall points may conceal specific domain disparities that local reviews could verify.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Cowfold Surgery1200.081.6%70.0%86.7%
    Village Surgery1170.070.4%65.8%78.8%
    Rudgwick1090.063.6%60.0%70.7%
    Courtyard1070.040.1%55.7%65.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHorshamAssetPCNHorsham
    Care homes (catchment)23 (951 beds)n/aSchools (catchment)67n/a
    Children's centres69Places of worship5693
    Libraries27Homelessness support (VCS)0no data
    Day centres (VCS)57Children and young people (VCS)n/a1
    Carers support groups (VCS)12Primary schools (LA maintained)2537
    Primary academies56Special schools33

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    COPD case-finding and review recall

    Recorded COPD prevalence is 1.2% (441 patients) versus 1.5% in Horsham and 1.9% in England (+83 to +228 range), while annual review coverage fell 2.9% over 2023 to 2025 (England +2.8%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 2

    Dementia register coding and care-home check

    Dementia prevalence is 0.5% (190 patients) against 0.9% in Horsham and 0.8% in England (+86 to +140 range), after falling 8.0% over 2023 to 2025 (England +6.0%). Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Option 3

    Learning disability register validation

    Learning disability prevalence is 0.4% (142 patients) compared with 0.5% in Horsham and 0.6% in England (+35 to +66 range), with +2.9% three-year growth trailing England (+5.4%). For discussion, practices could validate learning disability registers by checking diagnostic codes and cross-referencing with social-care or education records where data sharing permits. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Inclusion health case finding (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Breast screening recall audit (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Telephony access workflow review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · COPD case-finding and review recall (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 2 · Dementia register coding and care-home check (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15